Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC
05 Aug 2026
bởiStephen Padilla
Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.
Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC
05 Aug 2026
Resistance training lifts life quality in people with multiple sclerosis
04 Aug 2026
bởiStephen Padilla
Individuals with multiple sclerosis may benefit from resistance training, which has been shown in a recent study to potentially improve quality of life (QoL), particularly in the domains related to physical and mental health.







